Clinical Trials Browser

Phase 1 × Colony-Stimulating Factors × CNS × Clear all

Neoplasms, Neuroblastoma

NCT02444546 2023-04-24

Wild-Type Reovirus in Combination With Sargramostim in Treating Younger Patients With High-Grade Relapsed or Refractory Brain Tumors

Diffuse Intrinsic Pontine Glioma, Astrocytoma, Brain Neoplasms, Glioma, Medulloblastoma, Oligodendroglioma, Neuroectodermal Tumors, Primitive, Rhabdoid Tumor

NCT01250470 2017-02-27

Vaccine Therapy and Sargramostim in Treating Patients With Malignant Glioma

Phase 1 Completed

9 enrolled

CNSSarcoma

Astrocytoma, Brain Neoplasms, Glioblastoma, Glioma, Oligodendroglioma, Gliosarcoma

NCT01403285 2014-05-19

Peptide-based Glioma Vaccine IMA950 in Patients With Glioblastoma

Phase 1 Terminated

6 enrolled

CNS

Glioblastoma

Clinical Trials

RAPID

Wild-Type Reovirus in Combination With Sargramostim in Treating Younger Patients With High-Grade Relapsed or Refractory Brain Tumors

Vaccine Therapy and Sargramostim in Treating Patients With Malignant Glioma

Peptide-based Glioma Vaccine IMA950 in Patients With Glioblastoma